MediPharm Labs Corp. (LABS) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Thank you for standing by and welcome to the MediPharm Labs conference call to discuss the second quarter 2025 results. Our speakers on today's call are David Piddock, President and Chief Executive Officer, and Greg Hunter, Chief Financial Officer. As a reminder, all participants are in the listen-only mode and the conference is being recorded. After management's presentation, we will take written questions through the Q&A feature on the webcast. The information contained on this presentation should be considered together with the more detailed information, disclosure, financial data and statements available on the company's website and on CDR Plus profile. As seen on slide two and three, I would like to note that this earnings call contains forward-looking information and is based on the company's current expectations, estimates, and beliefs as of today's date, and will also use terms that are non-IFRS financial measures. Please review the company's most recent disclosure material for the risks associated with the use of forward-looking information and the use of non-IFRS financial measures in this presentation. Please note that all dollar amounts mentioned in today's call are in Canadian dollars unless otherwise noted. And now I would like to turn the call over to Mr. David Piddock. Please go ahead. Thank you, operator. Good morning and thank you for joining us for MediPharm Labs' second quarter earnings call. As you saw in the news release we issued earlier this morning, we delivered solid operational and financial results with 14% revenue growth over the prior year while successfully defending MetaFarm in a proxy contest and executing effectively on our strategic priorities. Let me begin by sincerely thanking our shareholders. Your support and engagement during t...